Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Tailored vaccine may hold the key to treating eczema in children

New research from a multi-disciplinary team at Trinity College Dublin suggests a "tailored vaccine" might hold the key to treating bacteria-driven flares of eczema in children.

8 May 2024

Health impacts and demographic inequities from nitrogen dioxide emissions in US homes using gas and propane stoves

Indoor nitrogen dioxide (NO2) emissions from gas and propane stoves and assessed their health impacts.

8 May 2024

Chronic disease increases the odds of hospitalization from heat exposure, study finds

The impact of ambient heat exposure on hospitalizations among individuals with varying numbers and combinations of chronic diseases.

8 May 2024

Innovative methodologies for investigating intestinal mucus properties and response

As much as we might not want to think about it, mucus is everywhere in our bodies. It coats our airways and our digestive systems and serves as a first line of defense against pathogens, a habitat for our microbiomes, and a conveyor belt for our insides to keep everything moving smoothly.

7 May 2024

Empowering asthma patients through education

On World Asthma Day 2024 the message is clear: "Asthma Education Empowers." The Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, stresses the crucial role of education in empowering people with asthma to manage their condition effectively and to know when to seek medical assistance.

7 May 2024

Could better inhalers help patients, and the planet?

Miguel Divo, a lung specialist at Brigham and Women's Hospital in Boston, sits in an exam room across from Joel Rubinstein, who has asthma. Rubinstein, a retired psychiatrist, is about to get a checkup and hear a surprising pitch — for the planet, as well as his health.

6 May 2024

Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged

Severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs).

3 May 2024

Deciphering the role of Th2-multipotent progenitor cells in chronic allergic inflammation

Currently, most therapies for allergic diseases require lifelong treatment. Allergic reactions, characterized by ongoing (type 2) inflammation in response to chronic antigen exposure, underlie many chronic diseases in humans, including asthma, atopic dermatitis, ulcerative colitis and more.

30 Apr 2024

Study investigates the potential effects of neonatal vitamin D on eczema up to adulthood

Australian researchers find that higher neonatal vitamin D levels are associated with lower odds of early-onset persistent eczema but an increased risk of early-onset resolving eczema in children up to age 25.

30 Apr 2024

Study links long-term health risks with burn pit exposure in military veterans

Study links extended deployments at military bases with open burn pits to a higher risk of developing respiratory and cardiovascular diseases, including COPD, asthma, and hypertension in veterans.

28 Apr 2024

Harnessing immune enhancement to combat drug-resistant tuberculosis

Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the drug-resistant forms of the disease.

26 Apr 2024

Personalized risk prediction tool helps prioritize high-risk infants for RSV prevention

A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April), according to Vanderbilt University Medical Center (VUMC) research published in Open Forum Infectious Diseases and to be presented at the American Thoracic Society 2024 International Conference.

25 Apr 2024

PCORI funds more than $150 million to support new patient-centered clinical effectiveness research

The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling more than $150 million to support new patient-centered comparative clinical effectiveness research (CER) studies, research to strengthen the rigor and quality of patient-centered CER and a project to implement the findings of PCORI-funded research into practice.

23 Apr 2024

Asthma News and Research

Further Reading

Tailored vaccine may hold the key to treating eczema in children

Health impacts and demographic inequities from nitrogen dioxide emissions in US homes using gas and propane stoves

Chronic disease increases the odds of hospitalization from heat exposure, study finds

Innovative methodologies for investigating intestinal mucus properties and response

Empowering asthma patients through education

Could better inhalers help patients, and the planet?

Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged

Deciphering the role of Th2-multipotent progenitor cells in chronic allergic inflammation

Study investigates the potential effects of neonatal vitamin D on eczema up to adulthood

Study links long-term health risks with burn pit exposure in military veterans

Harnessing immune enhancement to combat drug-resistant tuberculosis

Personalized risk prediction tool helps prioritize high-risk infants for RSV prevention

PCORI funds more than $150 million to support new patient-centered clinical effectiveness research

New QR4 algorithm outperforms previous models in predicting cardiovascular disease risk

Unsheltered people are losing Medicaid in redetermination mix-ups

Higher zinc intake linked to lower asthma risk in overweight kids

Boosted immunity: Study reveals longevity of COVID-19 booster shots

Understanding the unique types and triggers of asthma

Study highlights how age affects nasal cell response to SARS-CoV-2

Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News